查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621816

dPCR 和 qPCR 市场：按产品、应用和最终用户划分 - 2025-2030 年全球预测

dPCR & qPCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical Application, Forensic Applications, Research Application), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年dPCR和qPCR市值为80.5亿美元，预计到2024年将达到88.8亿美元，复合年增长率为10.23%，到2030年将达到159.4亿美元。

数位 PCR (dPCR) 和定量 PCR (qPCR) 是广泛应用于生物和医学研究中定量 DNA 和 RNA 的先进分子技术。对这些技术的需求源于其高精度、高灵敏度和较低的污染风险，这对于临床诊断、基因研究和法医学分析的应用至关重要。这些技术的最终用途涵盖製药、生物技术、农业和环境研究等不同领域，同时在病原体检测、基因表现分析和基因组研究等领域也至关重要。影响市场成长的主要驱动因素包括感染疾病的流行、遗传疾病的增加、精准医疗的普及。最近的技术进步，例如基于液滴的 dPCR 系统，透过实现高通量和自动化处理能力提供了巨大的潜在机会。为了利用这些进步，公司应该加强与研究机构的合作，并投资开发适合特定应用的易于使用、经济高效的套件。然而，由于设备成本高、资料解释复杂以及潜在最终用户（尤其是新兴地区）认知度低，市场面临限制。透过策略定价模型和强大的培训计划来应对这些挑战可能会提高市场渗透率。创新和研究将集中于开发用于即时现场应用的可携式整合系统、增强检测多重分析能力以及提高准确性和速度，以扩大 dPCR 和 qPCR 在治疗领域的效用。该市场充满活力，其特点是强大的竞争格局推动了主要企业的创新。希望在这个市场取得成功的公司将优先考虑战略联盟，专注于利用下一代技术扩展产品系列，并积极响应新的法规和标准，以确保其解决方案能够持续不断地满足不断变化的需求。和农业。

主要市场统计
基准年[2023] 80.5亿美元
预计年份 [2024] 88.8亿美元
预测年份 [2030] 159.4亿美元
复合年增长率（%） 10.23%

市场动态：揭示快速发展的 dPCR 和 qPCR 市场的关键市场洞察

供应和需求的动态交互作用正在改变 dPCR 和 qPCR 市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 感染疾病和遗传患者病率上升
    • 更多使用 dPCR 和 qPCR 来有效提供个人化医疗
    • 更多采用食品检测程序以确保安全和消费
  • 市场限制因素
    • dPCR 和 qPCR高成本
  • 市场机会
    • PCR技术的技术进步
    • 增加对全球基因组学研究计划的资助
  • 市场挑战
    • 与 dPCR 和 qPCR 技术相关的技术限制和资料分析复杂性

波特五力：驾驭 dPCR 和 qPCR 市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 dPCR 和 qPCR 市场的外部影响

外部宏观环境因素在塑造 dPCR 和 qPCR 市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解 dPCR 和 qPCR 市场的竞争格局

对 dPCR 和 qPCR 市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 dPCR 和 qPCR 市场供应商绩效评估

FPNV定位矩阵是评估dPCR和qPCR市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製 dPCR 和 qPCR 市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 dPCR 和 qPCR 市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病和遗传疾病的传播
      • 增加使用 dPCR 和 qPCR 来高效提供个人化医疗
      • 改善食品检测程序的采用，确保食品安全与消费
    • 抑制因素
      • dPCR 和 qPCR高成本
    • 机会
      • PCR技术的技术进步
      • 全球基因组研究计划的资金增加
    • 任务
      • 与 dPCR 和 qPCR 技术相关的技术限制和资料分析复杂性
  • 市场区隔分析
    • 产品：快速检测基因序列的先进PCR设备的普及
    • 应用：在感染监测和检测的临床应用中利用 dPCR 和 qPCR
    • 最终用户：学术机构对PCR技术的学术研究和关注不断增长
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 dPCR 和 qPCR 市场：副产品

  • 装置
  • 试剂/耗材
  • 软体和服务

第 7 章 dPCR 和 qPCR 市场：依应用分类

  • 临床应用
    • 验血
    • 肿瘤检查
    • 病原体检测
  • 法医学应用
  • 调查申请

第 8 章 dPCR 和 qPCR 市场：按最终用户划分

  • 学术研究所
  • 合约调查机构
  • 医院和护理提供者
  • 製药和生物技术公司

第9章 美洲dPCR和qPCR市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区dPCR和qPCR市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的 dPCR 和 qPCR 市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • QIAGEN 扩大了其针对生物製药行业的数位 PCR套件和服务阵容
    • Virax Biolabs Group Limited 签署马尔堡病毒 PCR检测套组经销协议
    • Thermo Fisher Scientific 推出全新数位 PCR 自动化解决方案
  • 战略分析和建议

公司名单

  • 10x Genomics, Inc.
  • Abbott Laboratories
  • accela sro
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMed Central Ltd
  • BioMerieux SA
  • Canopy Biosciences, LLC
  • Combinati Inc.
  • Danaher Corporation
  • F. Hoffman-La Roche Ltd.
  • GE Healthcare Inc.
  • JN Medsys Pte. Ltd.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Pfizer Inc.
  • Promega Corporation
  • QIAGEN NV by Thermo Fisher Scientific, Inc.
  • Roche Holding AG
  • Siemens Healthineers AG
  • Stilla Technologies SA
  • Takara Bio Inc.
  • Vela Diagnostics
Product Code: MRR-430D3EB720F1

The dPCR & qPCR Market was valued at USD 8.05 billion in 2023, expected to reach USD 8.88 billion in 2024, and is projected to grow at a CAGR of 10.23%, to USD 15.94 billion by 2030.

Digital PCR (dPCR) and quantitative PCR (qPCR) are advanced molecular technologies used extensively in biological and medical research for quantifying DNA and RNA. The necessity for these technologies arises from their high precision, sensitivity, and reduction in risk of contamination, crucial for applications in clinical diagnostics, genetic research, and forensic analysis. The end-use scope of these technologies spans across diverse sectors including pharmaceuticals, biotechnology, agriculture, and environmental studies, whilst being pivotal in areas such as pathogen detection, gene expression analysis, and genomic studies. Key drivers influencing market growth include the increasing prevalence of infectious diseases, rising incidences of genetic disorders, and widespread adoption of precision medicine. Recent technological advancements, such as droplet-based dPCR systems, offer significant potential opportunities by enabling high-throughput and automated processing capabilities. To capitalize on these advancements, businesses should foster collaborations with research institutions and invest in developing user-friendly, cost-effective kits tailored for specific applications. However, the market faces limitations due to high equipment costs, complexity in data interpretation, and limited awareness among potential end-users, particularly in emerging regions. Addressing these challenges through strategic pricing models and robust training programs could expand market penetration. Innovation and research should focus on developing portable, integrated systems for real-time field applications, enhancing assay multiplexing capabilities, and improving accuracy and speed to broaden the utility of dPCR and qPCR in therapeutic areas. The market is dynamic, characterized by a strong competitive landscape with key players driving innovation. Firms looking to thrive in this market should prioritize strategic alliances, focus on expanding their product portfolio with next-gen technologies, and proactively adapt to emerging regulations and standards to ensure their solutions meet the evolving needs of the life sciences and agricultural sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 8.05 billion
Estimated Year [2024] USD 8.88 billion
Forecast Year [2030] USD 15.94 billion
CAGR (%) 10.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving dPCR & qPCR Market

The dPCR & qPCR Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of infectious diseases and genetic disorders
    • Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
    • Improving adoption in food testing procedures to ensure safety and consumption
  • Market Restraints
    • High cost associated with dPCR and qPCR
  • Market Opportunities
    • Technological advancements in PCR technologies
    • Growing funding for genomics research projects worldwide
  • Market Challenges
    • Technical limitations and data analysis complexities associated with dPCR and qPCR techniques

Porter's Five Forces: A Strategic Tool for Navigating the dPCR & qPCR Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the dPCR & qPCR Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the dPCR & qPCR Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the dPCR & qPCR Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the dPCR & qPCR Market

A detailed market share analysis in the dPCR & qPCR Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the dPCR & qPCR Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the dPCR & qPCR Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the dPCR & qPCR Market

A strategic analysis of the dPCR & qPCR Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the dPCR & qPCR Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, accela s.r.o., Agilent Technologies, Inc., Analytik Jena GmbH, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., BioMed Central Ltd, BioMerieux S.A., Canopy Biosciences, LLC, Combinati Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., GE Healthcare Inc., JN Medsys Pte. Ltd., Merck KGaA, PerkinElmer, Inc., Pfizer Inc., Promega Corporation, QIAGEN N.V. by Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers AG, Stilla Technologies SA, Takara Bio Inc., and Vela Diagnostics.

Market Segmentation & Coverage

This research report categorizes the dPCR & qPCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Application, market is studied across Clinical Application, Forensic Applications, and Research Application. The Clinical Application is further studied across Blood Screening, Oncology Testing, and Pathogen Testing.
  • Based on End-User, market is studied across Academic Research & Institutes, Contract Research Organizations, Hospitals & Care Providers, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of infectious diseases and genetic disorders
      • 5.1.1.2. Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
      • 5.1.1.3. Improving adoption in food testing procedures to ensure safety and consumption
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with dPCR and qPCR
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in PCR technologies
      • 5.1.3.2. Growing funding for genomics research projects worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and data analysis complexities associated with dPCR and qPCR techniques
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding presence of sophisticated PCR instruments for rapid detection of genetic sequences
    • 5.2.2. Application: Utilization of dPCR and qPCR in clinical applications for infection monitoring and detection
    • 5.2.3. End-user: Rising focus of academic research and academic institutes toward PCR technologies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. dPCR & qPCR Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Software & Services

7. dPCR & qPCR Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Application
    • 7.2.1. Blood Screening
    • 7.2.2. Oncology Testing
    • 7.2.3. Pathogen Testing
  • 7.3. Forensic Applications
  • 7.4. Research Application

8. dPCR & qPCR Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research & Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Hospitals & Care Providers
  • 8.5. Pharmaceutical & Biotechnology Companies

9. Americas dPCR & qPCR Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific dPCR & qPCR Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa dPCR & qPCR Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. QIAGEN Expands Range of Digital PCR Kits and Services for the Biopharma Industry
    • 12.3.2. Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
    • 12.3.3. Thermo Fisher Scientific Launches New Digital PCR Automation Solution
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Abbott Laboratories
  • 3. accela s.r.o.
  • 4. Agilent Technologies, Inc.
  • 5. Analytik Jena GmbH
  • 6. Becton Dickinson and Company
  • 7. Bio-Rad Laboratories, Inc.
  • 8. BioMed Central Ltd
  • 9. BioMerieux S.A.
  • 10. Canopy Biosciences, LLC
  • 11. Combinati Inc.
  • 12. Danaher Corporation
  • 13. F. Hoffman-La Roche Ltd.
  • 14. GE Healthcare Inc.
  • 15. JN Medsys Pte. Ltd.
  • 16. Merck KGaA
  • 17. PerkinElmer, Inc.
  • 18. Pfizer Inc.
  • 19. Promega Corporation
  • 20. QIAGEN N.V. by Thermo Fisher Scientific, Inc.
  • 21. Roche Holding AG
  • 22. Siemens Healthineers AG
  • 23. Stilla Technologies SA
  • 24. Takara Bio Inc.
  • 25. Vela Diagnostics

LIST OF FIGURES

  • FIGURE 1. DPCR & QPCR MARKET RESEARCH PROCESS
  • FIGURE 2. DPCR & QPCR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DPCR & QPCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DPCR & QPCR MARKET DYNAMICS
  • TABLE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DPCR & QPCR MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DPCR & QPCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DPCR & QPCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DPCR & QPCR MARKET SIZE, BY FORENSIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DPCR & QPCR MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DPCR & QPCR MARKET SIZE, BY ACADEMIC RESEARCH & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DPCR & QPCR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DPCR & QPCR MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DPCR & QPCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023